Ultime notizie per Aprea Therapeutics (NASDAQ:APRE) Azioni

APREA THERAPEUTICS INC

Aprea Therapeutics

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

Earnings

Press Releases

Aprea Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Health Care

Aprea Therapeutics Announces Twice Daily (BID) Dosing of Patients in ABOYA-119 Clinical Trial of ATRN-119 to Potentially Optimize Clinical Outcomes and Strengthen Clinical Path Forward

News

Legal

Aprea Therapeutics Announces Strategic IP Portfolio Evolution in DNA Damage Response (DDR) Cancer Therapeutics

Contracts

Aprea Therapeutics Announces Agreement with MD Anderson Cancer Center to Explore APR-1051 as a Potential Treatment for Head and Neck Squamous Cell Carcinoma (HNSCC)

Aprea Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update

Aprea Therapeutics Announces Dosing of Patient with HPV+ Head and Neck Squamous Cell Carcinoma (HNSCC) in Ongoing ACESOT-1051 Trial

Adicet Bio Appoints Michael Grissinger to the Board of Directors

Adicet Bio Reports First Quarter 2025 Financial Results and Provides Business Updates

Aprea Therapeutics Reports First Quarter 2025 Financial Results and Provides a Clinical Update

General

Aprea Reports Anti-Proliferative Results and Promising Early-Stage Clinical Data for Next-Generation WEE1 Inhibitor, APR-1051, in HPV+ Head and Neck Squamous Cell Carcinoma (HNSCC) in Collaboration with MD Anderson Cancer Center

ACET

APRE

Acurx Pharmaceuticals, Inc. - Common Stock

Acurx Pharmaceuticals

AEON Biopharma, Inc. Class A Common Stock

AEON Biopharma

Aptevo Therapeutics

BioCardia

Brainstorm Cell Therapeutics Inc. - Common Stock

Brainstorm Cell

bioAffinity Technologies, Inc. - Common Stock

bioAffinity Technologies

Bolt Biotherapeutics, Inc. - Common Stock

Bolt Biotherapeutics

Cellectar Biosciences, Inc. - Common Stock

Cellectar Biosciences

CEL-SCI

Cyclerion Therapeutics, Inc. - Common Stock

Cyclerion Therapeutics

Dogwood Therapeutics, Inc. - Common Stock

Dogwood Therapeutics

Equillium

Genprex

Geovax Labs

GT Biopharma

HCW Biologics

Immuron Limited - American Depositary Shares

Immuron

Intensity Therapeutics, Inc. - Common Stock

Intensity Therapeutics

PharmaCyte Biotech

Pelthos Therapeutics

TAO Synergies

Alaunos Therapeutics, Inc. - Common Stock

Alaunos Therapeutics

Tharimmune

Turnstone Biologics

XTL Biopharmaceuticals Ltd. - American Depositary Shares

Comments

Aprea Therapeutics

Notizie

Ultime notizie per Aprea Therapeutics (NASDAQ:APRE) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO